BioCentury | Feb 1, 2020
Company News

Any chance left for safer opioids?

...Pink:ZCOR) with a new focus on non-opioid analgesics through the acquisition of four programs from Iroko Pharmaceuticals LLC...
BioCentury | Sep 18, 2018
Company News

Management tracks: BioTime, Immune-Onc

...James as EVP and general counsel. She was SVP, general counsel and corporate secretary at Iroko Pharmaceuticals LLC...
BioCentury | Jul 13, 2016
Company News

Management tracks

...Shire plc (LSE:SHP; NASDAQ:SHPG) acquired. de Garidel is to become Ipsen's non-executive chairman. Pain play Iroko Pharmaceuticals LLC...
...replacing founder Osagie Imasogie. Vollmer, who already holds a board seat, will continue to be Iroko's...
BioCentury | Jul 11, 2016
Financial News

Iroko financial update

...Iroko Pharmaceuticals LLC , Philadelphia, Pa. Business: Neurology, Autoimmune Date announced: 2016-06-29 Note: Iroko secured a...
BioCentury | Feb 22, 2016
Company News

Iroko sales and marketing update

...Vivlodex is a low-dose formulation of the NSAID meloxicam that uses SoluMatrix Fine Particle technology. Iroko Pharmaceuticals LLC...
BioCentury | Nov 9, 2015
Clinical News

Meloxicam regulatory update

...FDA approved an NDA from Iroko for Vivlodex meloxicam to treat osteoarthritis (OA) pain. The product...
...product is a low-dose formulation of the NSAID meloxicam that uses SoluMatrix Fine Particle technology. Iroko Pharmaceuticals LLC...
BioCentury | Aug 17, 2015
Company News

Iroko sales and marketing update

...orally three times a day or 40 mg orally two or three times a day. Iroko Pharmaceuticals LLC...
BioCentury | Jul 27, 2015
Company News

Iroko, Laboratorios Saval deal

...and osteoarthritis pain. Iroko declined to provide further details, and Saval could not be reached. Iroko Pharmaceuticals LLC...
BioCentury | Jun 8, 2015
Company News

Iroko, Litha Healthcare, Endo deal

...Inc. (Philadelphia, Pa.). Endo declined to provide further details, and Iroko could not be reached. Iroko Pharmaceuticals LLC...
BioCentury | Mar 23, 2015
Clinical News

SoluMatrix meloxicam regulatory update

...FDA accepted for review an NDA for Iroko’s SoluMatrix meloxicam to treat osteoarthritis pain. Iroko declined...
...product is a low-dose formulation of the NSAID meloxicam that uses SoluMatrix Fine Particle technology. Iroko Pharmaceuticals LLC...
Items per page:
1 - 10 of 95
BioCentury | Feb 1, 2020
Company News

Any chance left for safer opioids?

...Pink:ZCOR) with a new focus on non-opioid analgesics through the acquisition of four programs from Iroko Pharmaceuticals LLC...
BioCentury | Sep 18, 2018
Company News

Management tracks: BioTime, Immune-Onc

...James as EVP and general counsel. She was SVP, general counsel and corporate secretary at Iroko Pharmaceuticals LLC...
BioCentury | Jul 13, 2016
Company News

Management tracks

...Shire plc (LSE:SHP; NASDAQ:SHPG) acquired. de Garidel is to become Ipsen's non-executive chairman. Pain play Iroko Pharmaceuticals LLC...
...replacing founder Osagie Imasogie. Vollmer, who already holds a board seat, will continue to be Iroko's...
BioCentury | Jul 11, 2016
Financial News

Iroko financial update

...Iroko Pharmaceuticals LLC , Philadelphia, Pa. Business: Neurology, Autoimmune Date announced: 2016-06-29 Note: Iroko secured a...
BioCentury | Feb 22, 2016
Company News

Iroko sales and marketing update

...Vivlodex is a low-dose formulation of the NSAID meloxicam that uses SoluMatrix Fine Particle technology. Iroko Pharmaceuticals LLC...
BioCentury | Nov 9, 2015
Clinical News

Meloxicam regulatory update

...FDA approved an NDA from Iroko for Vivlodex meloxicam to treat osteoarthritis (OA) pain. The product...
...product is a low-dose formulation of the NSAID meloxicam that uses SoluMatrix Fine Particle technology. Iroko Pharmaceuticals LLC...
BioCentury | Aug 17, 2015
Company News

Iroko sales and marketing update

...orally three times a day or 40 mg orally two or three times a day. Iroko Pharmaceuticals LLC...
BioCentury | Jul 27, 2015
Company News

Iroko, Laboratorios Saval deal

...and osteoarthritis pain. Iroko declined to provide further details, and Saval could not be reached. Iroko Pharmaceuticals LLC...
BioCentury | Jun 8, 2015
Company News

Iroko, Litha Healthcare, Endo deal

...Inc. (Philadelphia, Pa.). Endo declined to provide further details, and Iroko could not be reached. Iroko Pharmaceuticals LLC...
BioCentury | Mar 23, 2015
Clinical News

SoluMatrix meloxicam regulatory update

...FDA accepted for review an NDA for Iroko’s SoluMatrix meloxicam to treat osteoarthritis pain. Iroko declined...
...product is a low-dose formulation of the NSAID meloxicam that uses SoluMatrix Fine Particle technology. Iroko Pharmaceuticals LLC...
Items per page:
1 - 10 of 95